Home > Boards > US OTC > Cannabis > Medical Marijuana, Inc. (MJNA)
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Ecostate
And Then 106
Posts 16,963
Boards Moderated 6
Alias Born 10/02/03
MJNA
Current Price
Volume:
MJNA Detailed Quote
PURA Pop Potential From Under $.03 To $.15 After Gap Accessible To $.04 InvestorsHub NewsWire – 3/3/2020 2: 38: 20 PM
PURA PPS Periodic Surge Bolstered By Post COVID-19 Market Rally InvestorsHub NewsWire – 2/25/2020 11: 08: 40 AM
Puration Inc (OTCMKTS: PURA) Pursues Acquisition Of Smaller Cannabis Infusion Companies InvestorsHub NewsWire – 2/4/2020 2: 20: 47 PM
A Fresh Type of Cannabis Customers-The CBD Pet Product Industry is rising InvestorsHub NewsWire – 8/28/2019 11: 00: 00 AM
PURA Lining Up For Run From $.07 To $.25 On Technical Breakout With Bullish MACD Cross Pushing 200 Day MA InvestorsHub NewsWire – 6/10/2019 12: 12: 21 PM
Maintaining Our Pets: More CBD Pet Products Arriving at Market Drive Quality and private Equity Innovation InvestorsHub NewsWire – 4/29/2019 7: 00: 00 AM
Latest Report Shows Quickly Increasing Variety of Consumers Using CBD Infused Products InvestorsHub NewsWire – 4/2/2019 10: 36: 18 AM
Marijuana Stocks Big Announcement Coming Soon for 2019 InvestorsHub NewsWire – 3/31/2019 3: 49: 14 PM
Ecostate Thursday, 03/19/20 04: 04: 51 PM
Re: None
Post # of 224143
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent australia wide because of its Novel Monotherapeutic Compounds to help remedy PNS and CNS Disorders
9: 00 am ET March 19, 2020 (PR Newswire) Print
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the earliest-possibly publicly traded cannabis business in the us that introduced the world’s 1st-possibly marijuana-derived nutraceutical items, manufacturers and supply chain, reported these days that its stock portfolio expenditure provider Kannalife, Inc. (“Kannalife”) (OTCQB: KLFE) continues to be supplied Australian Patent AU2015204609B2 (the “Patent”) particular to “Novel Functionalized 1,3-Benzene Diols and their Procedure for Use for the management of Hepatic Encephalopathy.” With this Patent, Kannalife now contains six patents across the globe.
“Medical Marijuana, Inc. and our profile of providers just like Kannalife are committed to increasing information and recognition of cannabis and cannabinoid-similar reports worldwide,” said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. “Kannalife is pushing forward that aim with new patents in half a dozen nations.”
KLS-13019 prospects Kannalife’s intellectual property or home estate of unique, monotherapeutic molecules (“KLS Family”), which are designed for working as neuroprotective substances and have the potential to take care of a range of conditions, as well as central nervous system, oxidative strain, and neurodegenerative conditions.
“On this Patent, we are thankful that a great number of areas have accepted our IP property as creative and exclusive,” mentioned Dean Petkanas, CEO of Kannalife. “We have seen this as an significant action toward commercializing our head substance aspirant KLS-13019 in several trading markets in the foreseeable future, including the Australian pharmaceutical drug sector, which can be supposed to access $32.1 billion in 2020 all alone.”
From the 7 patents issued to Kannalife about this modern technology, two are U.S. patents and five are foreign patents declaring consideration to Kannalife’s authentic 2014 U.S. submitting day via international application PCT/US2015/010827, that was published as WO2015/106108A2 titled, “Novel Functionalized 1,3-Benzene Diols in addition to their Means of Use for treating Hepatic Encephalopathy” (the “PCT Patent”).
Additionally, Kannalife has countrywide step patent software according to the PCT Patent application pending in Canada, Brazil and India.
About KLS-13019KLS-13019 is Kannalife’s primary investigational, exclusive and creative monotherapeutic item for the likely management of various neurodegenerative and neuropathic discomfort diseases, beginning with radiation treatment-caused peripheral neuropathy (CIPN). KLS-13019 is not reviewed or accepted for affected person use with the U.S. Medication and Meal Administration (FDA) as well as other medical care authority across the world. It’s efficacy and safeness have not been proved by FDA-approved investigation.
About Kannalife, Inc.Kannalife, Inc. is a biopharmaceutical med-chem business aimed at the growth of amazing and trademarked unique monotherapeutic molecules for clients struggling with unmet medical requires of neurodegenerative problems – such as radiation treatment-stimulated peripheral neuropathy (CIPN), a continual neuropathy due to noxious chemotherapeutic brokers hepatic encephalopathy (HE), a neurotoxic mind-liver ailment a result of excessive levels of ethanol and ammonia on the mind slight disturbing mental faculties damage (mTBI), a disorder associated with one and repeating affect injury and chronic stressful encephalopathy (CTE), a condition linked to remarkably recurrent affect traumas in qualified and beginner sports activities.
The Company’s KLS Group of proprietary substances focuses on curing oxidative strain-connected illnesses for instance HE, recurring suffering from neuropathies like CIPN, and neurodegenerative diseases like CTE. Kannalife conducts its analysis and creation hard work within the Pennsylvania Biotechnology Center of Bucks County in Doylestown, PA.
To find out more about Kannalife, Inc., go to www.kannalife.com and visit the Company’s Twitter site at @Kannalife.
About Medical Marijuana, Inc.We have been a business of firsts. Medical Marijuana, Inc. (MJNA) is often a marijuana organization with about three different business models during the low-psychoactive cannabinoid room or space: a worldwide stock portfolio of cannabinoid-primarily based nutraceutical brands brought by Kannaway and HempMeds a pioneer in finding the greatest-good quality legal low-psychoactive cannabis items resulting from manufacturing hemp as well as a cannabinoid-centered clinical investigation and organic pharmaceutical progression field guided by its pharmaceutic purchase companies and collaborators as well as AXIM Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was called a top-notch CBD producer by CNBC. Medical Marijuana, Inc. had also been the primary company to acquire historic import enables for CBD solutions out of the government authorities of Brazil,Mexico and Argentina, and Paraguay and is a leader in the growth of worldwide sells. The company’s primary product Real Scientific Hemp Oil has been utilized in a few prosperous clinical studies all through Mexico and Brazil to grasp its basic safety and efficacy.
Medical Marijuana, Inc.’s headquarters is at San Diego, Ca, California, and additional data is offered by OTCMarkets.com or when you go to www.medicalmarijuanainc.com. To discover Medical Marijuana, Inc.’s company video recording, click the link.
Shareholders and customers are also encouraged to acquire CBD oil as well as other solutions at Medical Marijuana, Inc.’s store.
FORWARD-LOOKING DISCLAIMERThis touch relieve could have particular forwards-searching information and assertions, as outlined in the concept of Section 27A on the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subjected to the Safe Harbor put together by those areas. This material contains phrases about anticipated potential activities and monetary success that will be frontward-shopping in subject matter and character to uncertainties and potential risks. Such ahead-shopping assertions by definition call for potential risks, uncertainties as well as other things, which may increase the risk for specific results, effectiveness or achievements of Medical Marijuana, Inc. to always be materially totally different from the statements created herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese assertions have not been assessed from the Medication and Meal Administration. The product is just not meant to heal, deal with and detect or stop any condition.